MRP Capital Investments’s Amedisys AMED Stock Holding History

MRP Capital Investments’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25	Closed	-$2.46K	–	203
2025 Q3	$2.46K	Buy	+25	New	+$2.46K	﹤0.01%	191
2025 Q2	–	Sell	-595	Closed	-$55.1K	–	195
2025 Q1	$55.1K	Buy	595 +280	+89%	+$25.8K	0.05%	134
2024 Q4	$28.6K	Sell	315 -12,850	-98%	-$1.18M	0.03%	138
2024 Q3	$1.27M	Sell	13,165 -3,400	-21%	-$332K	1.21%	27
2024 Q2	$1.52M	Sell	16,565 -2,365	-12%	-$219K	1.42%	21
2024 Q1	$1.74M	Sell	18,930 -865	-4%	-$81.1K	1.75%	15
2023 Q4	$1.88M	Buy	19,795 +16,185	+448%	+$1.51M	2.02%	10
2023 Q3	$337K	Buy	+3,610	New	+$334K	0.37%	77

Other funds holding AMED

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

MRP Capital Investments's AMED Position: Q4 2025 in Review

MRP Capital Investments sold out of Amedisys (AMED) in Q4 2025, closing a stake of 25 shares — an estimated $2.46K sold.

MRP Capital Investments first reported a position in AMED in Q3 2023 and held it in 8 quarters. The position peaked at $1.88M in Q4 2023. 1 fund tracked by Wall St. Rank holds AMED as of Q4 2025.

MRP Capital Investments reported no remaining Amedisys position as of Q4 2025 after selling out during the quarter.
MRP Capital Investments sold 25 Amedisys shares in Q4 2025, an estimated $2.46K.
MRP Capital Investments first reported a position in Amedisys in Q3 2023 and held it in 8 quarters.
MRP Capital Investments's Amedisys position peaked at $1.88M in Q4 2023.
1 fund tracked by Wall St. Rank held Amedisys as of Q4 2025.

Based on MRP Capital Investments's 13F filing for Q4 2025, filed 9 Feb 2026.